On the heels of announcing the close of $8.2 million in seed funding, TripleBlind is pleased to announce that it has expanded its collaboration with Mayo Clinic. The renowned academic medical center invested in a seed extension round and was the only investor participating.
TripleBlind is collaborating with Mayo Clinic on data-analysis, algorithm training and validation on one-way encrypted data and on next generation algorithm sharing. TripleBlind’s API-driven virtual exchange solution allows Mayo Clinic researchers to validate interoperability of encrypted algorithms on encrypted data and train new algorithms on private data.
“As part of our mission to commercialize innovative technologies for the benefit of patients worldwide, we are furthering our collaboration with TripleBlind through this investment,” said Andy Danielsen, Chair, Mayo Clinic Ventures.
Mayo Clinic joins Accenture Ventures, Okta Ventures, NextGen Venture Partners, Operator Partners, Wavemaker Three-Sixty Health, AVG Basecamp Fund, Anorak Ventures, Quiet Capital, Clocktower Technology Ventures, Parity Responsible Technology Fund and Manresa Ventures as a TripleBlind investor.
Through TripleBlind’s solution, organizations can share data and collaborate without decrypting the data, enforcing HIPAA and other data standards, and create more ethical consumer and patient profiles.